vs
GigaCloud Technology Inc（GCT）与Orthofix Medical Inc.（OFIX）财务数据对比。点击上方公司名可切换其他公司
GigaCloud Technology Inc的季度营收约是Orthofix Medical Inc.的1.5倍（$332.6M vs $219.9M），GigaCloud Technology Inc净利率更高（11.2% vs -1.0%，领先12.2%），GigaCloud Technology Inc同比增速更快（9.7% vs 2.0%），GigaCloud Technology Inc自由现金流更多（$77.1M vs $16.8M），过去两年GigaCloud Technology Inc的营收复合增速更高（36.6% vs 8.0%）
GigaCloud Technology Inc是一家美国电商企业，主打家具、家电、健身器材等体积较大、规格不统一商品的B2B交易，旗下拥有线上B2B交易平台，业务覆盖撮合交易、全程物流直至终端配送环节。公司总部位于加利福尼亚州埃尔蒙特，自2022年8月起在纳斯达克挂牌上市。
Orthofix医疗是全球知名骨科医疗器械企业，专注于研发、生产及销售脊柱植入物、骨科创伤产品、骨生长刺激治疗设备及再生医疗产品，服务全球多地的骨科医师与医疗机构，致力于提升肌肉骨骼疾病患者的诊疗效果。
GCT vs OFIX — 直观对比
营收规模更大
GCT
是对方的1.5倍
$219.9M
营收增速更快
GCT
高出7.7%
2.0%
净利率更高
GCT
高出12.2%
-1.0%
自由现金流更多
GCT
多$60.2M
$16.8M
两年增速更快
GCT
近两年复合增速
8.0%
损益表 — Q3 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $332.6M | $219.9M |
| 净利润 | $37.2M | $-2.2M |
| 毛利率 | 23.2% | 71.1% |
| 营业利润率 | 12.2% | 0.2% |
| 净利率 | 11.2% | -1.0% |
| 营收同比 | 9.7% | 2.0% |
| 净利润同比 | -8.6% | 92.4% |
| 每股收益（稀释后） | $0.99 | $-0.05 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收GCTOFIX
| Q4 25 | — | $219.9M | ||
| Q3 25 | $332.6M | $205.6M | ||
| Q2 25 | $322.6M | $203.1M | ||
| Q1 25 | $271.9M | $193.6M | ||
| Q4 24 | $295.8M | $215.7M | ||
| Q3 24 | $303.3M | $196.6M | ||
| Q2 24 | $310.9M | $198.6M | ||
| Q1 24 | $251.1M | $188.6M |
净利润GCTOFIX
| Q4 25 | — | $-2.2M | ||
| Q3 25 | $37.2M | $-22.8M | ||
| Q2 25 | $34.6M | $-14.1M | ||
| Q1 25 | $27.1M | $-53.1M | ||
| Q4 24 | $31.0M | $-29.1M | ||
| Q3 24 | $40.7M | $-27.4M | ||
| Q2 24 | $27.0M | $-33.4M | ||
| Q1 24 | $27.2M | $-36.0M |
毛利率GCTOFIX
| Q4 25 | — | 71.1% | ||
| Q3 25 | 23.2% | 72.2% | ||
| Q2 25 | 23.9% | 68.7% | ||
| Q1 25 | 23.4% | 62.8% | ||
| Q4 24 | 22.0% | 69.0% | ||
| Q3 24 | 25.5% | 68.7% | ||
| Q2 24 | 24.6% | 67.8% | ||
| Q1 24 | 26.5% | 67.5% |
营业利润率GCTOFIX
| Q4 25 | — | 0.2% | ||
| Q3 25 | 12.2% | -8.3% | ||
| Q2 25 | 11.1% | -7.9% | ||
| Q1 25 | 10.4% | -25.2% | ||
| Q4 24 | 9.3% | -5.3% | ||
| Q3 24 | 13.4% | -9.6% | ||
| Q2 24 | 8.8% | -12.5% | ||
| Q1 24 | 13.9% | -15.6% |
净利率GCTOFIX
| Q4 25 | — | -1.0% | ||
| Q3 25 | 11.2% | -11.1% | ||
| Q2 25 | 10.7% | -6.9% | ||
| Q1 25 | 10.0% | -27.4% | ||
| Q4 24 | 10.5% | -13.5% | ||
| Q3 24 | 13.4% | -13.9% | ||
| Q2 24 | 8.7% | -16.8% | ||
| Q1 24 | 10.8% | -19.1% |
每股收益（稀释后）GCTOFIX
| Q4 25 | — | $-0.05 | ||
| Q3 25 | $0.99 | $-0.57 | ||
| Q2 25 | $0.91 | $-0.36 | ||
| Q1 25 | $0.68 | $-1.35 | ||
| Q4 24 | $0.76 | $-0.76 | ||
| Q3 24 | $0.98 | $-0.71 | ||
| Q2 24 | $0.65 | $-0.88 | ||
| Q1 24 | $0.66 | $-0.95 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $365.9M | $82.0M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $457.3M | $450.0M |
| 总资产 | $1.1B | $850.6M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资GCTOFIX
| Q4 25 | — | $82.0M | ||
| Q3 25 | $365.9M | $62.9M | ||
| Q2 25 | $303.0M | $65.6M | ||
| Q1 25 | $286.8M | $58.0M | ||
| Q4 24 | $302.4M | $83.2M | ||
| Q3 24 | $259.8M | $30.1M | ||
| Q2 24 | $207.8M | $26.4M | ||
| Q1 24 | $195.3M | $27.0M |
总债务GCTOFIX
| Q4 25 | — | — | ||
| Q3 25 | — | $157.2M | ||
| Q2 25 | — | $157.0M | ||
| Q1 25 | — | $156.9M | ||
| Q4 24 | — | $157.0M | ||
| Q3 24 | — | $118.5M | ||
| Q2 24 | — | $118.0M | ||
| Q1 24 | — | $118.2M |
股东权益GCTOFIX
| Q4 25 | — | $450.0M | ||
| Q3 25 | $457.3M | $442.5M | ||
| Q2 25 | $431.4M | $458.3M | ||
| Q1 25 | $412.9M | $458.3M | ||
| Q4 24 | $405.2M | $503.1M | ||
| Q3 24 | $400.4M | $525.9M | ||
| Q2 24 | $358.4M | $546.0M | ||
| Q1 24 | $317.8M | $570.3M |
总资产GCTOFIX
| Q4 25 | — | $850.6M | ||
| Q3 25 | $1.1B | $832.6M | ||
| Q2 25 | $1.1B | $837.2M | ||
| Q1 25 | $1.1B | $823.1M | ||
| Q4 24 | $1.1B | $893.3M | ||
| Q3 24 | $1.1B | $867.9M | ||
| Q2 24 | $1.1B | $882.0M | ||
| Q1 24 | $977.6M | $906.0M |
负债/权益比GCTOFIX
| Q4 25 | — | — | ||
| Q3 25 | — | 0.36× | ||
| Q2 25 | — | 0.34× | ||
| Q1 25 | — | 0.34× | ||
| Q4 24 | — | 0.31× | ||
| Q3 24 | — | 0.23× | ||
| Q2 24 | — | 0.22× | ||
| Q1 24 | — | 0.21× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $78.3M | $27.7M |
| 自由现金流经营现金流 - 资本支出 | $77.1M | $16.8M |
| 自由现金流率自由现金流/营收 | 23.2% | 7.6% |
| 资本支出强度资本支出/营收 | 0.4% | 4.9% |
| 现金转化率经营现金流/净利润 | 2.10× | — |
| 过去12个月自由现金流最近4个季度 | $188.1M | $-1.3M |
8季度趋势，按日历期对齐
经营现金流GCTOFIX
| Q4 25 | — | $27.7M | ||
| Q3 25 | $78.3M | $12.4M | ||
| Q2 25 | $38.6M | $11.6M | ||
| Q1 25 | $9.4M | $-18.4M | ||
| Q4 24 | $68.4M | $23.7M | ||
| Q3 24 | $55.2M | $11.7M | ||
| Q2 24 | $19.1M | $9.0M | ||
| Q1 24 | $15.3M | $-18.6M |
自由现金流GCTOFIX
| Q4 25 | — | $16.8M | ||
| Q3 25 | $77.1M | $2.5M | ||
| Q2 25 | $37.0M | $4.5M | ||
| Q1 25 | $7.0M | $-25.1M | ||
| Q4 24 | $66.9M | $15.2M | ||
| Q3 24 | $51.4M | $6.3M | ||
| Q2 24 | $12.9M | $-360.0K | ||
| Q1 24 | $11.3M | $-29.1M |
自由现金流率GCTOFIX
| Q4 25 | — | 7.6% | ||
| Q3 25 | 23.2% | 1.2% | ||
| Q2 25 | 11.5% | 2.2% | ||
| Q1 25 | 2.6% | -13.0% | ||
| Q4 24 | 22.6% | 7.0% | ||
| Q3 24 | 16.9% | 3.2% | ||
| Q2 24 | 4.2% | -0.2% | ||
| Q1 24 | 4.5% | -15.4% |
资本支出强度GCTOFIX
| Q4 25 | — | 4.9% | ||
| Q3 25 | 0.4% | 4.8% | ||
| Q2 25 | 0.5% | 3.5% | ||
| Q1 25 | 0.9% | 3.5% | ||
| Q4 24 | 0.5% | 4.0% | ||
| Q3 24 | 1.3% | 2.7% | ||
| Q2 24 | 2.0% | 4.7% | ||
| Q1 24 | 1.6% | 5.6% |
现金转化率GCTOFIX
| Q4 25 | — | — | ||
| Q3 25 | 2.10× | — | ||
| Q2 25 | 1.12× | — | ||
| Q1 25 | 0.35× | — | ||
| Q4 24 | 2.21× | — | ||
| Q3 24 | 1.36× | — | ||
| Q2 24 | 0.71× | — | ||
| Q1 24 | 0.56× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
GCT
| Services | $108.4M | 33% |
| Transferred Over Time | $89.8M | 27% |
| Product Sales To B | $50.1M | 15% |
| Last Mile Delivery Service | $49.2M | 15% |
| Warehousing Service | $14.2M | 4% |
| Ocean Transportation Service | $9.0M | 3% |
| Platform Commission | $4.9M | 1% |
| Drayage Service | $3.2M | 1% |
OFIX
| Spinal Implants Biologics And Enabling Technologies | $113.6M | 52% |
| Bone Growth Therapies | $68.3M | 31% |
| Other | $22.7M | 10% |
| IT | $5.9M | 3% |
| GB | $3.5M | 2% |
| FR | $3.5M | 2% |
| DE | $2.3M | 1% |
